Isolation of multiple carbapenemase-producing Gram-negative bacilli from a patient recently hospitalized in Nigeria

Diagnostic Microbiology and Infectious Disease

Volumn 81, Issue 4, 2015, Pages 296-298

  Walkty, Andrew ^a,b   Gilmour, Matthew ^a,b   Simner, Patricia ^a,b   Embil, John M ^a   Boyd, David ^c   Mulvey, Michael ^a,c   Karlowsky, James ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b Diagnostic Services of Manitoba Inc   (Canada)

^c PUBLIC HEALTH AGENCY OF CANADA   (Canada)

Author keywords

Carbapenemase; Gram negative bacilli; NDM 1; VIM 2

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZTREONAM; CARBAPENEM; CARBAPENEMASE; CEFAZOLIN; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; ERTAPENEM; GENTAMICIN; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; TIGECYCLINE; TOBRAMYCIN; BACTERIAL PROTEIN; BETA LACTAMASE;

ADULT; ANALYTICAL EQUIPMENT; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL GENE; BACTERIUM CULTURE; BACTERIUM ISOLATION; CANADA; CARBAPENEMASE PRODUCING GRAM NEGATIVE BACILLUS; CASE REPORT; FEMALE; FEMUR FRACTURE; GES GENE; GRAM NEGATIVE BACTERIUM; HUMAN; IMP GENE; INFECTION PREVENTION; KLEBSIELLA PNEUMONIAE; KPC GENE; MINIMUM INHIBITORY CONCENTRATION; NDM GENE; NIGERIA; ORTHOPEDIC SURGERY; OXA 181 GENE; OXA 48 GENE; PHENOTYPE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; TERTIARY HEALTH CARE; TIBIA FRACTURE; TRAFFIC ACCIDENT; VIM GENE; ENZYMOLOGY; ESCHERICHIA COLI; GENETICS; GRAM NEGATIVE INFECTION; HETEROZYGOTE; HOSPITALIZATION; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; SECRETION (PROCESS);

ADULT; BACTERIAL PROTEINS; BACTERIOLOGICAL TECHNIQUES; BETA-LACTAMASES; CANADA; CARRIER STATE; ESCHERICHIA COLI; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HOSPITALIZATION; HUMANS; KLEBSIELLA PNEUMONIAE; NIGERIA; PSEUDOMONAS AERUGINOSA;

EID: 84925066522     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2015.01.005     Document Type: Article

References (20)

1. Bathoorn E., Friedrich A.W., Zhou K., Arends J.P., Borst D.M., Grundmann H., et al. Latent introduction to the Netherlands of multiple antibiotic resistance including NDM-1 after hospitalization in Egypt, August 2013. Euro Surveill 2013, 18. [pii:20610http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20610].
2. Clinical and Laboratory Standards Institute (CLSI) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved Standard (M7-A9) 2012, CLSI, Wayne, PA, USA. 9th ed.
3. Clinical and Laboratory Standards Institute (CLSI) Performance standards for antimicrobial susceptibility testing. 24nd Informational Supplement (M100-S24) 2014, CLSI, Wayne, PA, USA.
4. Dortet L., Poirel L., Anguel N., Nordmann P. New Delhi metallo-β-lactamase 4-producing Escherichia coli in Cameroon. Emerg Infect Dis 2012, 18:1540-1542.
5. Mataseje L.F., Bryce E., Roscoe D., Boyd D.A., Embree J., Gravel D., et al. Carbapenem-resistant Gram-negative bacilli in Canada 2009-10: results from the Canadian Nosocomial Infection Surveillance System (CNISP). J Antimicrob Chemother 2012, 67:1359-1367.
6. Mataseje L.F., Boyd D.A., Hoang L., Imperial M., Lefebvre B., Miller M., et al. Carbapenem-hydrolyzing oxacillinase-48 and oxacillinase-181 in Canada, 2011. Emerg Infect Dis 2013, 19:157-160.
7. Mulvey M.R., Grant J.M., Plewes K., Roscoe D., Boyd D.A. New Delhi metallo-β-lactamase in Klebsiella pneumoniae and Escherichia coli, Canada. Emerg Infect Dis 2011, 17:103-106.
8. Nordmann P., Poirel L. Strategies for identification of carbapenemase-producing Enterobacteriaceae. J Antimicrob Chemother 2013, 68:487-489.
9. Nordmann P., Poirel L., Dortet L. Rapid detection of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis 2012, 18:1503-1507.
10. Ogbolu D.O., Webber M.A. High-level and novel mechanisms of carbapenem resistance in Gram-negative bacteria from tertiary hospitals in Nigeria. Int J Antimicrob Agents 2014, 43:412-417.
11. Peirano G., Ahmed-Bentley J., Woodford N., Pitout J.D. New Delhi metallo-β-lactamase from traveler returning to Canada. Emerg Infect Dis 2011, 17:242-244.
12. Peirano G., Ahmed-Bentley J., Fuller J., Rubin J.E., Pitout J.D.D. Travel-related carbapenemase-producing Gram-negative bacteria in Alberta, Canada: the first 3 years. J Clin Microbiol 2014, 52:1575-1581.
13. Pitout J.D.D., Chow B.L., Gregson B.D., Laupland K.B., Elsayed S., Church D.L. Molecular epidemiology of metallo-β-lactamase-producing Pseudomonas aeruginosa in the Calgary health region: emergence of VIM-2-producing isolates. J Clin Microbiol 2007, 45:294-298.
14. Poirel L., Benouda A., Hays C., Nordmann P. Emergence of NDM-1 producing Klebsiella pneumoniae in Morocco. J Antimicrob Chemother 2011, 66:2781-2783.
15. Rubin J.E., Peirano G., Peer A.K., Govind C.N., Pitout J.D.D. NDM-1-producing Enterobacteriaceae from South Africa: moving towards endemicity?. Diagn Microbiol Infect Dis 2014, 79:378-380.
16. Sassi A., Loucif L., Gupta S.K., Dekhil M., Chettibi H., Rolain J.M. NDM-5 carbapenemase-encoding gene in multidrug-resistant clinical isolates of Escherichia coli from Algeria. Antimicrob Agents Chemother 2014, 58:5606-5608.
17. Sepehri S., Poliquin G., Alfattoh N., Boyd D., Mulvey M., Denisuik A., et al. Osteomyelitis due to multiple carbapenemase-producing Gram-negative bacteria: the first case report of a GES-13-producing Pseudomonas aeruginosa isolate in Canada. Can J Infect Dis Med Microbiol 2014, 25:229-231.
18. Simner P.J., Gilmour M.W., DeGagne P., Nichol K., Karlowsky J.A. Evaluation of five chromogenic agar media and the ROSCO Rapid CARB Screen kit for the detection and confirmation of carbapenemase production in Gram-negative bacilli. J Clin Microbiol 2015, 53:105-112.
19. Tijet N., Macmullin G., Lastovetska O., Vermeiren C., Wenzel P., Stacey-Works T., et al. Verona integron-encoded metallo-β-lactamase 1 in Enterobacteriaceae, Ontario, Canada. Emerg Infect Dis 2013, 19:1156-1158.
20. Walsh T.R. Emerging carbapenemases: a global perspective. Int J Antimicrob Agents 2010, 36S3:S8-S14.